Renal protection: progression, regression, remission from nephropathy beyond blood pressure control.
Mario Negri Institute for Pharmacological Research, Negri Bergamo Laboratories, Italy.
G
G
Remuzzi
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D007678:Kidney Glomerulus / Q000503:physiopathology; D008297:Male; D011507:Proteinuria / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D017257:Ramipril / Q000627:therapeutic use; D012074:Remission Induction; D017582:Renal Replacement Therapy
D000806:Angiotensin-Converting Enzyme Inhibitors; D017257:Ramipril